🚛 Free Shipping Over $50
Glycemic Manager® 60 tablets Integrative Therapeutics
Couldn't load pickup availability
SUPPORTS HEALTHY BLOOD SUGAR METABOLISM AND A HEALTHY INSULIN RESPONSE
A unique glucose support formula to promote healthy post-prandial glucose metabolism. Glycemic Manager™ supports healthy blood sugar metabolism. This formula, which combines essential nutrients and botanicals, supports a healthy insulin response and lessens the impact of foods with high Glycemic Index.
DIRECTIONS
Glycemic Manager® Directions and/or Dosage
Adults take 2 tablets daily with food, or as recommended by a healthcare professional.Warning
If you are pregnant, nursing, or taking any medications, consult a healthcare professional before use. Individuals with diabetes should monitor blood glucose levels closely while taking this product. Keep out of reach of children. Safety sealed with inner seal. Do not use if seal is broken or missing. Keep tightly closed. Store at room temperature. Avoid excessive heat and direct sunlight.FAQS
Q: Is is safe for individuals with diabetes to take Glycemic Manager®?
A: Yes, Glycemic Manager® can be safely taken by individuals with diabetes. Glycemic Manager® contains myricetin, which has been shown to enhance the activity of several cellular components which aid in the transport of glucose from the blood into cells, as well as nineteen other ingredients that promote healthy blood glucose metabolism.* However, we recommend that individuals consult with their licensed healthcare practitioner prior to use. We also strongly encourage that individuals monitor their blood glucose levels on a regular basis, especially during the first weeks of adding the supplement to their regimen.
Q: Is Glycemic Manager® necessary for long term use?
A: Not necessarily. It may be possible for certain individuals to discontinue use of Glycemic Manager® if he or she is able to reach their goal levels. If an individual is able to adopt and maintain healthy lifestyle changes, such as daily exercise and healthy eating, their healthcare practitioner can then determine whether or not they can decrease their frequency/dose of Glycemic Manager®.
Q: Can Glycemic Manager®, be used by pregnant women for the support of pregancy related diabetes?
A: This product has not been tested on pregnant women. Due to the delicate nature of the developing fetus, we would not recommend the use of Glycemic Manager® during pregnancy.
Serving Size: 2 tablets
| Ingredient | Amount per Serving | %DV |
|---|---|---|
| Total Carbohydrate | <1g | <1%† |
| Thiamin (as thiamin HCl) | 56mg | 4,667% |
| Riboflavin (vitamin B2) | 56mg | 4,308% |
| Niacin (as niacinamide) | 37mg | 231% |
| Vitamin B6 (as pyridoxine HCl) | 25mg | 1,471% |
| Folate (240 mcg Folic Acid) (209 mcg Quatrefolic® brand (6S)-5-Methyltetrahydrofolate glucosamine salt) | 600 mcg DFE | 150% |
| Vitamin B12 (as methylcobalamin) | 375mcg | 15,625% |
| Biotin | 400mcg | 1,333% |
| Pantothenic Acid (as calcium D-pantothenate) | 37mg | 740% |
| Choline (as choline bitartrate) | 30mg | 5% |
| Magnesium (as magnesium oxide) | 200mg | 48% |
| Zinc (as zinc gluconate) | 15mg | 136% |
| Copper (as copper gluconate) | 1mg | 111% |
| Sodium | 5mg | <1% |
| Alpha Lipoic Acid | 250mg | ** |
| Bitter Melon (Momordica charantia) Fruit Extract | 200mg | ** |
| Gymnema (Gymnema sylvestre) Leaf Extract | 200mg | ** |
| Bayberry (Morella cerifera) Leaf and Bark Extract standardized to contain 80% myricetin | 100mg | ** |
| Cinnamon (Cinnamomum aromaticum) Bark Extract standardized to contain 8% flavonoids | 100mg | ** |
| Bilberry (Vaccinium myrtillus) Fruit Extract | 40mg | ** |
| Vanadium (as vanadyl sulfate) | 200mcg | ** |
Notes:
- DV (Daily Value) is not established for ingredients marked with **.
- † Percent daily value is based on a 2000 calorie diet.
Other Ingredients:
cellulose, sodium croscarmellose, stearic acid, silica, hypromellose, magnesium stearate, glycerin.
Glycemic Manager® Does Not Contain:
Gluten, Soy, Dairy, Colors, Wheat.
Additional Information:
Quatrefolic® is a registered trademark of Gnosis S.p.A. U.S. Patent No. 7,947,662.